UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters

Links shared publicly online about this topic.

  • 109
    total visits

UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters

reuters.com

* Drug will be commercially available in the US in Sept. July 29 (Reuters) - Biopharmaceutical company Bristol-MyersSquibb Co said the U.S. Food and Drug Administrationapproved a subcutaneous

View full resource at reuters.com

Tags: Rheumatoid Arthritis Medication, Diet and Nutrition, Drug, FDA, Orencia, Bristol-Myers Squibb

  • Share

Most Recently Shared on August 1, 2011 at 4:27 pm By:

forgrace Women In Pain

FDA approves self-injectable form of RA therapy Orencia... http://fb.me/1cL5Dybnp

10 months ago...

Also Shared By:

Drugs and Devices OW Drugs and Devices OW

Advertisement